Skip to main content

Infection

Featured Article

FDA Alert
News
05/01/2023
Priyam Vora
The U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally for the prevention of recurrence of Clostridioides difficile infection among adults.
The U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally for the prevention of recurrence of Clostridioides difficile infection among adults.
The U.S. Food and Drug...
05/01/2023
Gastroenterology
light bulb+idea+thinking+poll
Poll
01/10/2023
Regardless of ICU status, nearly 1 in 5 US patients hospitalized with COVID-19 have experienced gastrointestinal symptoms in some form, a multicenter cohort study confirmed. Which of the following issues have you seen among your patients who...
Regardless of ICU status, nearly 1 in 5 US patients hospitalized with COVID-19 have experienced gastrointestinal symptoms in some form, a multicenter cohort study confirmed. Which of the following issues have you seen among your patients who...
Regardless of ICU status, nearly...
01/10/2023
Gastroenterology
News
08/08/2022
Elevated liver enzymes among patients with COVID-19 were associated with increased risk of intensive care and mortality, according to a new study.
Elevated liver enzymes among patients with COVID-19 were associated with increased risk of intensive care and mortality, according to a new study.
Elevated liver enzymes among...
08/08/2022
Gastroenterology
Lab
Conference Coverage
05/22/2021
In fewer than 40 years, Helicobacter pylori has advanced from a disputed factor in causation of gastric ulcers to a bacterium that shows increasing resistance to antibiotic therapies.
In fewer than 40 years, Helicobacter pylori has advanced from a disputed factor in causation of gastric ulcers to a bacterium that shows increasing resistance to antibiotic therapies.
In fewer than 40 years,...
05/22/2021
Gastroenterology
News
05/21/2021
The American College of Gastroenterology updated its 2013 guideline on the diagnosis, treatment, and prevention of Clostridioides difficile to reflect changes in nomenclature, diagnostic methods, and treatments, including fecal microbial...
The American College of Gastroenterology updated its 2013 guideline on the diagnosis, treatment, and prevention of Clostridioides difficile to reflect changes in nomenclature, diagnostic methods, and treatments, including fecal microbial...
The American College of...
05/21/2021
Gastroenterology
News
04/21/2021
Fecal microbiota transplantation is widely used and considered safe in treating Clostridioides difficile infection.
Fecal microbiota transplantation is widely used and considered safe in treating Clostridioides difficile infection.
Fecal microbiota transplantation...
04/21/2021
Gastroenterology
News
04/21/2021
Gastroenteritis can be linked to increased risk of microscopic colitis diagnosis, research reveals.
Gastroenteritis can be linked to increased risk of microscopic colitis diagnosis, research reveals.
Gastroenteritis can be linked to...
04/21/2021
Gastroenterology
News
01/13/2021
A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
A new review reveals growing...
01/13/2021
Gastroenterology
Conference Coverage
10/29/2020
In the largest study to date on the significance of gastrointestinal symptoms associated with COVID-19 infection in the United States, researchers found that patients with nausea, diarrhea, and other gastric symptoms were more likely to need...
In the largest study to date on the significance of gastrointestinal symptoms associated with COVID-19 infection in the United States, researchers found that patients with nausea, diarrhea, and other gastric symptoms were more likely to need...
In the largest study to date on...
10/29/2020
Gastroenterology

News

FDA Alert
News
05/01/2023
Priyam Vora
The U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally for the prevention of recurrence of Clostridioides difficile infection among adults.
The U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally for the prevention of recurrence of Clostridioides difficile infection among adults.
The U.S. Food and Drug...
05/01/2023
Gastroenterology
News
08/08/2022
Elevated liver enzymes among patients with COVID-19 were associated with increased risk of intensive care and mortality, according to a new study.
Elevated liver enzymes among patients with COVID-19 were associated with increased risk of intensive care and mortality, according to a new study.
Elevated liver enzymes among...
08/08/2022
Gastroenterology
News
05/21/2021
The American College of Gastroenterology updated its 2013 guideline on the diagnosis, treatment, and prevention of Clostridioides difficile to reflect changes in nomenclature, diagnostic methods, and treatments, including fecal microbial...
The American College of Gastroenterology updated its 2013 guideline on the diagnosis, treatment, and prevention of Clostridioides difficile to reflect changes in nomenclature, diagnostic methods, and treatments, including fecal microbial...
The American College of...
05/21/2021
Gastroenterology
News
04/21/2021
Fecal microbiota transplantation is widely used and considered safe in treating Clostridioides difficile infection.
Fecal microbiota transplantation is widely used and considered safe in treating Clostridioides difficile infection.
Fecal microbiota transplantation...
04/21/2021
Gastroenterology
News
04/21/2021
Gastroenteritis can be linked to increased risk of microscopic colitis diagnosis, research reveals.
Gastroenteritis can be linked to increased risk of microscopic colitis diagnosis, research reveals.
Gastroenteritis can be linked to...
04/21/2021
Gastroenterology
News
01/13/2021
A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
A new review reveals growing...
01/13/2021
Gastroenterology
Research Highlights
06/11/2026
Jessica Garlewicz
A real-world cohort study found that patients with MASLD and type 2 diabetes who were not using GLP-1 RAs had a signficantly higher rate of hepatic complications compared to patients receiving GLP-1 therapy.
A real-world cohort study found that patients with MASLD and type 2 diabetes who were not using GLP-1 RAs had a signficantly higher rate of hepatic complications compared to patients receiving GLP-1 therapy.
A real-world cohort study found...
06/11/2026
Gastroenterology
Research Insights
06/09/2026
Rebecca Mashaw
New research highlights important similarities and differences between IBS-C and Parkinson’s disease–associated constipation
New research highlights important similarities and differences between IBS-C and Parkinson’s disease–associated constipation
New research highlights...
06/09/2026
Gastroenterology
Research Review
06/03/2026
Jessica Garlewicz
Investigators observed a lower cumulative incidence of CRC among individuals who underwent colonoscopy across both age groups studied.
Investigators observed a lower cumulative incidence of CRC among individuals who underwent colonoscopy across both age groups studied.
Investigators observed a lower...
06/03/2026
Gastroenterology
Research Insights
05/27/2026
Rebecca Mashaw
A new study adds to growing evidence that sexual and reproductive health issues are common yet frequently overlooked among younger colorectal cancer survivors.
A new study adds to growing evidence that sexual and reproductive health issues are common yet frequently overlooked among younger colorectal cancer survivors.
A new study adds to growing...
05/27/2026
Gastroenterology
Research Review
05/27/2026
Jessica Garlewicz
The findings provide reassurance regarding prognosis in patients presenting with multiple primary tumors.
The findings provide reassurance regarding prognosis in patients presenting with multiple primary tumors.
The findings provide reassurance...
05/27/2026
Gastroenterology
Research Review
05/06/2026
Jessica Garlewicz
Rehospitalization remained common among patients who experienced immune checkpoint inhibitor-associated colitis, indicating that adverse effects often persist beyond ICI exposure.
Rehospitalization remained common among patients who experienced immune checkpoint inhibitor-associated colitis, indicating that adverse effects often persist beyond ICI exposure.
Rehospitalization remained...
05/06/2026
Gastroenterology
Research Highlights
04/23/2026
Jessica Garlewicz
MetALD-ALD Prediction Index (MAP) proved to be the top-performing model among all commonly used indirect alcohol biomarkers.
MetALD-ALD Prediction Index (MAP) proved to be the top-performing model among all commonly used indirect alcohol biomarkers.
MetALD-ALD Prediction Index...
04/23/2026
Gastroenterology
News
02/11/2026
Jessica Garlewicz
For gastroenterologists, the key takeaway is that cumulative alcohol exposure and long-term drinking patterns matter when assessing CRC risk.
For gastroenterologists, the key takeaway is that cumulative alcohol exposure and long-term drinking patterns matter when assessing CRC risk.
For gastroenterologists, the key...
02/11/2026
Gastroenterology
Research Review
02/03/2026
Rebecca Mashaw
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from...
02/03/2026
Gastroenterology
Emerging Therapies
01/14/2026
Jessica Garlewicz
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating...
01/14/2026
Gastroenterology

Interactive

light bulb+idea+thinking+poll
Poll
01/10/2023
Regardless of ICU status, nearly 1 in 5 US patients hospitalized with COVID-19 have experienced gastrointestinal symptoms in some form, a multicenter cohort study confirmed. Which of the following issues have you seen among your patients who...
Regardless of ICU status, nearly 1 in 5 US patients hospitalized with COVID-19 have experienced gastrointestinal symptoms in some form, a multicenter cohort study confirmed. Which of the following issues have you seen among your patients who...
Regardless of ICU status, nearly...
01/10/2023
Gastroenterology
Quiz
08/07/2025
Rebecca Mashaw
What did researchers find in a recent study of patients with GERD and persistent reflux symptoms despite PPI therapy? Take our quick quiz to find out!
What did researchers find in a recent study of patients with GERD and persistent reflux symptoms despite PPI therapy? Take our quick quiz to find out!
What did researchers find in a...
08/07/2025
Gastroenterology
Quiz
08/07/2025
Rebecca Mashaw
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in...
08/07/2025
Gastroenterology
Quiz
08/07/2025
Rebecca Mashaw
Is there any association between esophageal disorders of gut-brain interaction and refractory reflux symptoms? Test your knowledge with our quick quiz!
Is there any association between esophageal disorders of gut-brain interaction and refractory reflux symptoms? Test your knowledge with our quick quiz!
Is there any association between...
08/07/2025
Gastroenterology
News
08/01/2025
Rebecca Mashaw
A prospective study reveals that more than 70% of patients with proven gastroesophageal reflux disease and refractory symptoms also exhibit features of esophageal disorders of gut-brain interaction.
A prospective study reveals that more than 70% of patients with proven gastroesophageal reflux disease and refractory symptoms also exhibit features of esophageal disorders of gut-brain interaction.
A prospective study reveals that...
08/01/2025
Gastroenterology
Quiz
07/18/2025
The TEMPO trial investigated techniques to improve return rates for fecal immunochemical tests for colorectal cancer. Find out what worked best by taking our quick quiz!
The TEMPO trial investigated techniques to improve return rates for fecal immunochemical tests for colorectal cancer. Find out what worked best by taking our quick quiz!
The TEMPO trial investigated...
07/18/2025
Gastroenterology
Quiz
07/18/2025
Rebecca Mashaw
Research has shown that several social determinants of health (SDOH) are associated with the prevalence of metabolic-associated steatotic liver disease. What has been identified as the most consistent associated SDOH?
Research has shown that several social determinants of health (SDOH) are associated with the prevalence of metabolic-associated steatotic liver disease. What has been identified as the most consistent associated SDOH?
Research has shown that several...
07/18/2025
Gastroenterology
Quiz
07/18/2025
Rebecca Mashaw
The prevalence of metabolic-associated steatotic liver disease (MASLD) is increasing. What will it be in the future? Take our quiz to find out.
The prevalence of metabolic-associated steatotic liver disease (MASLD) is increasing. What will it be in the future? Take our quiz to find out.
The prevalence of...
07/18/2025
Gastroenterology